World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
37958
World Ranking
17803
National Ranking
1617

Overview

Nicholas D. James is affiliated with the Institute of Cancer Research in the United Kingdom. Their research focus is situated primarily in the field of Medicine, with a strong emphasis on oncology and cancer-related studies. The scientist has contributed extensively to subfields such as Pulmonary and Respiratory Medicine, Surgery, Oncology, Radiology, Nuclear Medicine and Imaging, and Cancer Research.

Their work largely addresses topics in cancer treatments and diagnosis, particularly relating to prostate and bladder cancers. Major themes in their publications include:

  • Prostate Cancer Treatment and Research
  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Radiopharmaceutical Chemistry and Applications
  • Urinary and Genital Oncology Studies
  • Cancer, Lipids, and Metabolism
  • Cancer Immunotherapy and Biomarkers

Among their recent publications are the following significant papers:

  • The Lancet Commission on prostate cancer: planning for the surge in cases (2024, The Lancet)
  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 (2020, European Urology)
  • Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial (2020, The Lancet)
  • Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials (2021, The Lancet Oncology)
  • Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 (2023, European Journal of Cancer)

Nicholas D. James has collaborated frequently with several co-authors, including:

  • Noel W. Clarke
  • Matthew R. Sydes
  • Gerhardt Attard
  • Mahesh Parmar
  • Silke Gillessen

Their publications appear regularly in prominent journals, highlighting active engagement in the clinical oncology community. The most frequent publication venues include:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • European Urology
  • European Urology Oncology
  • The Journal of Urology

Best Publications

  • Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

    Ian F. Tannock;Ronald de Wit;William R. Berry;Jozsef Horti

  • Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

    C. Parker;S. Nilsson;S. Nilsson;D. Heinrich;S. I. Helle

  • Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

    Nicholas D. James;Johann S. de Bono;Melissa R. Spears;Noel W. Clarke

  • Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

    Nicholas D. James;Nicholas D. James;Matthew R. Sydes;Noel W. Clarke;Malcolm David Mason

  • Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

    Christopher C Parker;Nicholas D James;Christopher D Brawley;Noel W Clarke

  • Radiotherapy with or without Chemotherapy in muscle-invasive bladder cancer

    Nicholas D. James;Syed A. Hussain;Peter Jenkins;Jean Tremlett

  • The auxin influx carrier LAX3 promotes lateral root emergence

    Kamal Swarup;Eva Benková;Eva Benková;Ranjan Swarup;Ilda Casimiro

  • A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

    Maria Carmen Marin;Christine A. Jost;Louise A. Brooks;Meredith S. Irwin

  • A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor

    Jennifer C.C. Hu;Robert S. Coffin;Ceri J. Davis;Nicola J. Graham

  • Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

    Oliver Sartor;Robert E Coleman;Sten Nilsson;Daniel Heinrich

  • Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

    Nicholas David James;Melissa R. Spears;Noel W. Clarke;David P. Dearnaley

  • AUX/LAX Genes Encode a Family of Auxin Influx Transporters That Perform Distinct Functions during Arabidopsis Development

    Benjamin Péret;Kamal Swarup;Alison Ferguson;Malvika Seth

  • Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

    Claire L. Vale;Sarah Burdett;Larysa H. M. Rydzewska;Laurence Albiges

  • Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy : the SPARC trial

    Cora N. Sternberg;Daniel P. Petrylak;Oliver Sartor;J. Alfred Witjes

  • NASCArrays : a repository for microarray data generated by NASC's transcriptomics service

    David J. Craigon;Nick James;John Okyere;Janet Higgins

  • Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

    S Gillessen;A Omlin;G Attard;J S de Bono

  • Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

    N.W. Clarke;A. Ali;F.C. Ingleby;A. Hoyle

  • Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer : a systematic review

    Guillaume Ploussard;Siamak Daneshmand;Jason A. Efstathiou;Harry W. Herr

  • Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis

    S. C. Hillman;D. J. McMullan;G. Hall;F. S. Togneri

  • Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

    Christopher C Parker;Noel W Clarke;Adrian D Cook;Howard G Kynaston

Frequent Co-Authors

Matthew R. Sydes
Matthew R. Sydes University College London
Noel W. Clarke
Noel W. Clarke University of Salford
Chris Parker
Chris Parker Institute of Cancer Research
Malcolm David Mason
Malcolm David Mason Cardiff University
Maurice P. Zeegers
Maurice P. Zeegers Maastricht University
David P. Dearnaley
David P. Dearnaley Institute of Cancer Research
Mahesh K. B. Parmar
Mahesh K. B. Parmar University College London
Robert Huddart
Robert Huddart Institute of Cancer Research
Silke Gillessen
Silke Gillessen Universita della Svizzera Italiana
Gerhardt Attard
Gerhardt Attard University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t always require following the traditional path to becoming a medical doctor. A range of online degree options now enables students to pursue diverse health-related careers, often in more affordable and flexible ways.

For nurses seeking leadership roles, enrolling in one of the cheapest dnp programs can open doors to advanced clinical practice and administration. Pharmacists can gain their credentials through accredited online pharmd programs, allowing them to balance work while furthering their education.

If you’re interested in the administrative side of healthcare, consider an online rhit degree programs that focus on health information technology and patient data management. Additionally, medical billing and coding online courses offer a quick route into a high-demand healthcare field—perfect for those seeking flexible, entry-level opportunities.

These online degrees and courses provide accessible options for starting or advancing your healthcare career in the US, often with reduced tuition and flexible schedules.

Best Scientists Citing Nicholas D. James

Trending Scientists